Showing results (201-210 of 240) with videos related to
Sort By:
Pageof 24
Molecular Cell|December 21, 2024
Mutability and hypermutation antagonize immunoglobulin codon optimalityJoshua J C McGrath, Juyeon Park, Chloe A Troxell, et al.The Journal of Clinical Investigation|February 18, 2015
Preexisting human antibodies neutralize recently emerged H7N9 influenza strainsCarole J Henry Dunand, Paul E Leon, Kaval Kaur, et al.Science Translational Medicine|December 4, 2015
Immune history profoundly affects broadly protective B cell responses to influenzaSarah F Andrews, Yunping Huang, Kaval Kaur, et al.The Journal of Experimental Medicine|April 8, 2021
Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiationRahul Vijay, Jenna J Guthmiller, Alexandria J Sturtz, et al.Msphere|May 19, 2022
PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2Viviana Simon, Vamsi Kota, Ryan F Bloomquist, et al.Plos One|May 8, 2015
High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After VaccinationKaval Kaur, Nai-Ying Zheng, Kenneth Smith, et al.Cell Host & Microbe|June 10, 2016
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer ProtectionCarole J Henry Dunand, Paul E Leon, Min Huang, et al.Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humansAli H Ellebedy, Florian Krammer, Gui-Mei Li, et al.Acta Neuropathologica|October 13, 2016
Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patientsJacqueline R Rivas, Sara J Ireland, Rati Chkheidze, et al.Mbio|November 16, 2021
Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on SpikeSiriruk Changrob, Yanbin Fu, Jenna J Guthmiller, et al.Pageof 24